Effect of Acupuncture on Nausea, Vomiting, Pain, PGE2 and IL 6 in Septorhinoplasty

Sponsor
Kahramanmaras Sutcu Imam University (Other)
Overall Status
Completed
CT.gov ID
NCT04009070
Collaborator
(none)
70
1
2
8.5
8.2

Study Details

Study Description

Brief Summary

Acupuncture has emerged in China about 2,000 years ago and is one of the oldest medical procedures in the world.Later acupuncture was introduced to other regions such as Asia, Europe and the United States.The most extensive use of acupuncture is for pain relief.Especially, postoperative nausea and vomiting have been studied.In one study, PC6 (approximately two cm above the midline of the wrist line) showed antiemetic effect, with the addition of other acupuncture points, it proved to have a protective effect in the treatment of postoperative nausea and vomiting.ST36 (Approximately 1-2 cm laterally from the tuberocyte tibia) is an acupuncture point used in the treatment of diseases such as inflammation, acute pain, hypertension and gastrointestinal disorders.

Condition or Disease Intervention/Treatment Phase
  • Device: Acupuncture Pres Needle: 0.22x1.5 mm needle
N/A

Detailed Description

Patients will be determined as Group A: Acukupuncture group and Group C as Control group and 35 patients will be included in the study. Both groups will be given an intravenous (i.v) route in the preoperative patient room, PGE2, IL 6 will be taken for blood and 0.09% NaCl will be started. Group A preoperatively, 24 hours prior to bilateral PC6 (approximately two cm above the midline of the wrist line) and ST 36 (approximately 1-2 cm laterally from the Tibia) to be applied to the press needle (0.22x1.3 mm) and the tape (Needle Press will remain for 24 hours after surgery. Electrocardiography (ECG), noninvasive blood pressure (SBP-DBP), and peripheral arterial oxygen saturation (SpO2) monitoring will be applied to the patients. In the induction of anesthesia, Pentotal 5 mg / kg, Fentanyl 0.5 mcg / kg, and rocuronium 0.6 mg / kg will be used. Anesthesia maintenance will be provided with a 2% concentration of sevoflurane, 50% nitrous oxide (N2O) and 50% oxygen (O2) mixture and appropriately intubated. Patients will be recorded with systolic blood pressure (SBP), diastolic blood pressure (heart failure), heart rate (HR), mean arterial pressure (MAP) and SpO2, 5, 15, 30, 60, 120 minutes (min) after induction.

Patients in Group A and Group C had a saturation value of 97% or more, and exhaled if breathing effort was sufficient. Atropine and neostigmine will be used to neutralize muscle relaxants. Contramal 1mg / kg will be applied to the patients as standard by 20 minutes before the end of surgery. Following the termination of the surgical intervention, the anesthesia gases will be cut and 100% O2 will be inhaled with the mask until all the cases are compiled. 5.dk follow-up and extubation period of the patients will be taken to the postoperative rest room after being followed up on the operating table. 30. Min follow-up will be sent to their services after being done here. Postoperative 60 min, 3 h, 6 h, 12 h, 24 h, sore throat, nausea, vomiting, cough, itching, dysphagia, sore throat and analgesic needs, whether pain, assessment will be made. VAS score will be used to evaluate pain. Paracetamol will be applied to all patients when analgesia needs. At 24 hours postoperatively, blood will be taken to look for PGE2 and IL6 values.Preoperative and postoperative PGE2 and IL 6 values will be compared between the groups of the acupuncture group and the control group.

Study Design

Study Type:
Interventional
Actual Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Group A: Acupuncture Group Group C: Control GroupGroup A: Acupuncture Group Group C: Control Group
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Effect of Acupuncture on Nausea, Vomiting, Pain, PGE2 and IL 6 in Septorhinoplasty Operations; Prospective, Randomized, Controlled Study
Actual Study Start Date :
Aug 15, 2019
Actual Primary Completion Date :
Apr 10, 2020
Actual Study Completion Date :
Apr 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Acupuncture

Group A: Acupuncture group:Group A: Acupunctur will be applied to the Acupunctur group 24 hours prior to bilateral PC6 (approximately two cm above the midline of the wrist line) and ST 36 (approximately 1-2 cm laterally on the tibia) . The tape (Needle Press) will stay for 24 hours. Needle Press: Pres Needle: 0.22x1.5 mm needle

Device: Acupuncture Pres Needle: 0.22x1.5 mm needle
Acupunctur group; Acupunctur preoperatively 24 hours before bilateral PC6 (approximately two cm above the midline of the wrist line) and ST 36 (approximately 1-2 cm laterally from the tuberocyte tibia). The tape (Needle Press) will remain for 24 hours after surgery.

No Intervention: Control Group

Group C: Control group

Outcome Measures

Primary Outcome Measures

  1. Change Pain Scores [5 minute,30 minute, 60 minute, 3 hours, 6 hours, 12 hours, 24 hours after the operation]

    VAS (Visual analog scale) Score. from 1 to 10 , 0: No pain, 10: 10 pain that can not be tolerated

  2. PG E2 [Change from baseline and concentration of preoperativ and postoperative values at 24.hours]

    To evaluate the impact on the circulating levels of PG E2 ng/ml

  3. IL 6 [Change from baseline and concentration of preoperativ and postoperative values at 24.hours]

    To evaluate the impact on the circulating levels of IL 6 ng/ml

  4. Nause and Vomiting [After operation at 5 minutes, 30 minutes, 60 minutes,3 hours, 6 hours, 12 hours, 24 hours]

    Yes or No Nause and vomiting

Secondary Outcome Measures

  1. Blood Pressure [During operation at 5 minute, 15 minutes, 30 minutes, 60 minutes, 120 minutes and After operation at 5 minutes, 30 minutes, 60 minutes,3 hours, 6 hours, 12 hours, 24 hours after operation]

    Systolic blood pressue mmHg , diastolic blood pressure mmHg, mean arterial pressure mmHg,

  2. Heart rate [During operation at 5 minute, 15 minutes, 30 minutes, 60 minutes, 120 minutes and After operation at 5 minutes, 30 minutes, 60 minutes,3 hours, 6 hours, 12 hours, 24 hours]

    heart rate ,

  3. Change of Itching, cough, sore throat, difficulty in swallowing [Do Patients have any Itching, cough, sore throat, difficulty in swallowing in 5 minute,30 minute, 60 minute, 3 hours, 6 hours, 12 hours, 24 hours after operation]

    it will be asked if there are Itching, cough, sore throat, difficulty in swallowing.more in which group.

  4. oxygen follow-up [at 5 minute, 15 minutes, 30 minutes, 60 minutes, 120 minutes during]

    oxygen saturation

  5. oxygen follow-up [30 minutes, 60 minutes,3 hours, 6 hours, 12 hours, 24 hours after the operation,]

    oxygen saturation

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ASA I-II group

  • Aged 18-75

  • Volunteer to participate in the study

  • Conscious patients.

Exclusion Criteria:
  • Not wanting to participate

  • Unconscious

  • Having a hearing and speech problem

  • Allergic disease and bleeding disorder

  • Respiratory problems

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kahramanmaras Sutcu Imam University Faculty of Medicine Kahramanmaraş Onikişubat Turkey 251/A 46040

Sponsors and Collaborators

  • Kahramanmaras Sutcu Imam University

Investigators

  • Principal Investigator: yavuz orak, md, Kahramanmaraş Sutcu Imam University Faculty of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yavuz Orak, Assistant Professor, Kahramanmaras Sutcu Imam University
ClinicalTrials.gov Identifier:
NCT04009070
Other Study ID Numbers:
  • 2018/12-17
First Posted:
Jul 5, 2019
Last Update Posted:
Aug 12, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 12, 2022